Migraine Market Size, Share, Research, 2019 Global Industry Report, New Drug Development Pipeline, Competitive Analysis, Regional Forecast to 2022

Migraine Market Research Report - Forecast To 2022, Published by Market Research Future. Global Migraine Market Analysis by types (Episodic and Chronic), treatment type (Preventive and Abortive), drug class (Triptans, Ergots) - Forecast to 2022.

Pune, India - August 21, 2019 /MarketersMedia/ —

Migraine Market Scenario
The global migraine market is presumed to demonstrate a healthy CAGR during the appraisal period (2017-2022) owing to the rising cigarette consumption across the globe. Migraine is referred to as a chronic neurologic disease which is characterized by severe recurrent headaches. One of the most prevalent and common disabling neurological conditions, migraine is characterized by migraine attacks. They differ from regular headaches which are non-migrainous and have a lower threshold that might cause neuronal hyperexcitability, including environmental or emotional challenges, sleep disturbances, diet, alcohol exposure, and hormonal changes. Migraine is associated with neurological indications like vomiting, nausea, and painful sensitivity to lights and sounds.

Migraine Market Competitive Dashboard
The prominent players operating the global market are Eisai Inc., Kowa Pharmaceuticals America, Merck, AstraZeneca plc, Eli Lilly and Company, Johnson & Johnson, Meda, Pfizer Inc., Impax Laboratories, OptiNose, Allergan, Luitpold Pharmaceuticals, Abbott Laboratories Inc., Klaria, and GlaxoSmithKline Plc.

Request Free Sample @ https://www.marketresearchfuture.com/sample_request/2381

Migraine Market Drivers and Constraints Impacting the Market
The global migraine market is estimated to expand rapidly owing to the rising female population across the globe. With increasing healthcare expenditure, growing cigarette consumption, accelerating economic growth, and increasing prevalence of migraine and unmet needs, the global market for migraine is expected to flourish. Moreover, increasing awareness of migraine and its treatments coupled with development of migraine drugs are likely to stimulate the market growth. Also patient expirations are estimated to contribute to the market growth.

On the flip side, high cost, regulatory challenges, and lack of proper diagnosis are considered to dampen the market growth. Moreover, adverse effects of drugs and rising preferences of alternative therapies are presumed to hinder the market growth during the appraisal period.

Global Migraine Market: Segmental Analysis
The migraine market has been segmented on the basis of treatment types, types, drug class, and region.
By mode of type, the global migraine market has been segmented into chronic and episodic.
By mode of treatment type, the global migraine market has been segmented into abortive and preventive. Among these, the abortive treatment comprises therapeutic classes like ergot alkaloids, triptans, NSAIDs, and other non-specific drugs prescribed over-the-counter such as acetaminophen, aspirin, and ibuprofen. The preventive incorporates prescription of off-label and generic medications including beta blockers such as anti-epileptics and atenolol and propranolol like divalproex sodium and topiramate. In the current scenario, Amgen/Novartis’s Aimovig, Allergan’s Botox, and Teva’s Ajovy are the only drugs approved for migraine prevention.
By mode of drug class, the global migraine market has been segmented into ergots, triptans, and others.

Migraine Market Regional Insights
Geographically, migraine market span across Europe, North America, Asia Pacific, and the Middle East and Africa.
Among all the regions, the Asia Pacific region is considered to exhibit a significant growth rate owing to the rising focus of vendors on the emerging markets. The growth in this market is further attributed to the increasing demand for better healthcare facilities and improvements in the healthcare infrastructure. Moreover, this region represents remarkable opportunities for the investors and venture capitalists, as the developed markets are comparatively saturated. Such factors are likely to trigger the demand for migraine market during the appraisal period.

Migraine Industry Updates
November 15, 2018: Indianapolis-based Eli Lilly and Co. has recently applied for approval to the U.S. FDA regarding their new drug in order to treat migraine headaches. Lasmiditan will be used for the acute treatment of certain types of migraines in adults.

Browse Complete Report with TOC @ https://www.marketresearchfuture.com/reports/migraine-market-2381

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Info:
Name: Akash Anand
Email: Send Email
Organization: Market Research Future
Address: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India
Phone: 6468459312
Website: https://www.marketresearchfuture.com/reports/migraine-market-2381

Source URL: https://marketersmedia.com/migraine-market-size-share-research-2019-global-industry-report-new-drug-development-pipeline-competitive-analysis-regional-forecast-to-2022/88910471

Source: MarketersMedia

Release ID: 88910471

Other Sports News

Student shot at Texas high school; suspect still at large

Jan 27, 2020

BELLAIRE, Texas — A student was shot Tuesday at a high school in Texas and a suspect remained at large, local officials said. Emergency crews were seen performing CPR as the student was carried on a stretcher to an ambulance outside Bellaire High School, KPRC-TV reports. There were conflicting media reports about whether the shooting happened inside or outside the school. The city, a suburb south west of Houston, confirmed on Twitter that there was a shooting and said the suspect is still at large. It advised resident to avoid the area around the school or remain in their homes....

Oturu scores 30 as Minnesota beats No. 19 Michigan 75-67

Jan 27, 2020

MINNEAPOLIS — Daniel Oturu shook off an injury and had a career game to help Minnesota take down another ranked opponent. Oturu scored a career-high 30 points and the Gophers went on a late 11-0 run to beat No. 19 Michigan 75-67 on Sunday. The sophomore center had 20 points in a dominant first half, and he continued his roll with six quick points after the break. But with 14:35 remaining, he hit the deck hard while fighting for a rebound. He stayed on the floor for nearly five minutes, clutching his left shoulder as a hush fell over the...

Madrid beats Atlético in shootout, wins Spanish Super Cup

Jan 27, 2020

JEDDAH, Saudi Arabia — Real Madrid beat Atlético Madrid in a penalty shootout on Sunday to win the first edition of the new-look Spanish Super Cup that was held in Saudi Arabia despite criticism from human rights groups. Madrid won the shootout 4-1 after the final ended 0-0 after extra time. Dani Carvajal, Rodrygo, Luka Modric and Sergio Ramos all converted their spot kicks for Madrid. Atlético’s Saul Ñíguez missed his first penalty and Madrid goalkeeper Thibaut Courtois blocked the second attempt by Thomas Partey. Kieran Trippier converted for Atlético. “I had studied their penalty-takers before,” Courtois said. “I knew...

Bey scores 33, leads No. 16 Villanova past Georgetown 80-66

Jan 27, 2020

PHILADELPHIA — Saddiq Bey hit eight 3-pointers and scored a career-high 33 points to lead No. 16 Villanova to an 80-66 win over Georgetown on Saturday. Bey, a 6-foot-8 sophomore forward, hadn't been much of a 3-pointer shooter this season for the Wildcats (12-3, 3-1 Big East). He'd made only 21 and four of those came in a nonconference game against Ohio. He shot just 3-for-10 overall in a win this week at Creighton, hardly a sign he was about to bust out with a career game against the Hoyas (11-6, 1-3). Left open, and determined to shoot, Bey had...

Olympic champ David Gleirscher gets 1st World Cup luge win

Jan 27, 2020

ALTENBERG, Germany — Olympic champion David Gleirscher finally got his first World Cup luge victory, leading Austria’s sweep of gold Saturday. Gleirscher finished two runs at historic Altenberg in 1 minute, 48.150 seconds to hold off Italy’s Dominik Fischnaller by about one-quarter of a second. Fischnaller finished in 1:48.383 and Germany’s Felix Loch was third in 1:48.420. Gleirscher becomes the third different Austrian man to win a race this season. He’s 1 for 1 at the Olympics, after being the surprise winner of gold at the 2018 Pyeongchang Games. And he’s now 1 for 59 in World Cup races, getting...

Sukan360 is a proud Malaysian Sports website enthusiastic in our local players and bring Malaysian sports news first and foremost.

Soccer Racing Shootings Golf Sports Governance Men's Sports Women's Sports Press Releases